Pacira BioSciences, Inc.
Pacira BioSciences, Inc. (PCRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PCRX · as of Jun 8, 2026
Key Statistics
Explore Pacira BioSciences, Inc. Data
pcrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 36 · Buy rate: 41.7%
The PCRX analyst consensus is Hold, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $29.50, representing +29.10% upside from the current price of $22.85.
Competitors & Peers
pcrx competitorsPCRX
ANAB
BBOT
CRON
KOD
MNMDStock Performance
Full HistoryAbout Pacira BioSciences, Inc.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupiv…
what is pacira biosciences, inc. · pcrx stock overview · pacira biosciences, inc. company profile · who is pacira biosciences, inc. ceo · pcrx NASDAQ · pacira biosciences, inc. headquarters · pacira biosciences, inc. business segments
About Stock Overview & Key Data
Pacira BioSciences, Inc. (PCRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 3, 2011. As of the latest trading session, PCRX stock price is $22.85, with a market capitalization of $900.6M. The stock has returned -9.93% over the past 12 months and -11.53% year-to-date.
According to 36 Wall Street analysts, the consensus rating for Pacira BioSciences, Inc. stock is Hold, with an average 12-month price target of $29.50. In fiscal year 2025, Pacira BioSciences, Inc. reported revenue of $726.4M and net income of $7.0M. For detailed data — including Pacira BioSciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pacira BioSciences, Inc. (PCRX) stock price is $22.85. The stock is traded on NASDAQ under the ticker symbol PCRX. The 52-week range is $18.80 – $27.64.